Abuta

Abuta (Cissampelos pareira L.): A Comprehensive Reference

1. Identity, Taxonomy, and Nomenclature

1.1 Botanical Classification

Cissampelos pareira is a perennial climbing vine that belongs to the family Menispermaceae. The Menispermaceae family has a wide geographic distribution, mainly in tropical and subtropical regions of the world; its name is related to the crescent moon shape of the seeds. It is a slender tomentose climber. The leaves are peltate, 2.5–12 cm long, 2.5–11.5 cm broad, triangularly broad-ovate or orbicular, obtuse, mucronate, base cordate or truncate, ± tomentose on both sides; petiole pubescent. It is a climbing shrub with green leaves, orange to red drupe berries, horseshoe-shaped seeds, and brown to yellowish roots.

1.2 Common Names and Synonyms

Cissampelos pareira, commonly known as Abuta or Velvetleaf, is a medicinal plant that has a rich history of traditional use. In Brazil, this plant is well known as abutua, and in Peru it is known as abuta or barbasco. It is used in Chinese herbology, where it is called xí shēng téng (锡生藤) or yà hū nú (亞乎奴). The species is also known as abuta and called laghu patha in Ayurvedic medicine. It is commonly known as Bhatindupat in Punjab and laghupatha or ambastha in Indian traditional medicine. Additional synonyms and common names in global trade include abutua, aristoloche lobee, barbasco, bejuco de cerca, bejuco de raton, butua, false pareira, feuille coeur, gasing-gasing, ice vine, imchich masha, liane patte cheval, pareira, pareira brava, patacon, and velvetleaf.

1.3 A Critical Nomenclatural Distinction

The common name of this plant has caused confusion in herbal commerce. References to "abuta" in herbal commerce today may apply to either Cissampelos pareira or to a completely different plant, Abuta grandiflora. The latter is a very different plant with different chemicals and uses in herbal medicine. Although Abuta grandiflora is also a tropical climbing vine widely found in South America, it is completely different from Cissampelos pareira and contains altogether different compounds. Even the therapeutic uses of these two herbs are different. In Peru, Abuta grandiflora is known as chiric sanago and also abuta, which is the main reason behind the confusion. Furthermore, Abuta grandifolia is also referred to as abuta and is a South American medicinal plant used by indigenous people for making arrow poison. Researchers and consumers should therefore verify product identity using the full Latin binomial, Cissampelos pareira, to avoid substitution.

1.4 Geographic Distribution

The plant is commonly found on hilly tracts along watercourses, orchards, parks, hedges, and gardens of moist soils, either twining or creeping around other plants. It mainly occurs in Asia, East Africa, and America. Abuta is found throughout the Amazon in Peru, Brazil, Ecuador, and Colombia, and it is cultivated by many to beautify their gardens. It can also be found throughout the tropics and subtropics worldwide and is widely considered a weed in tropical climates.

2. Traditional and Historical Use

2.1 South American Indigenous and Mestizo Traditions

Cissampelos pareira (commonly known as Abuta) is a perennial vine with a long-standing role in Indigenous and mestizo medical systems across the Amazon and other tropical regions. Often regarded as a medicinal "teacher plant," Abuta features prominently in women's health — particularly for the management of menstrual disorders, postpartum recovery, and broader reproductive care.

In the rainforests of South America, Cissampelos pareira (called Abuta) has a rich history of use to treat all types of women's ailments including menstrual cramps, menorrhagia, and uterine haemorrhage. This is due to its profound relaxant effect on smooth muscle. Abuta is commonly referred to as the "midwife's herb" as it has been traditionally used in South America to combat women's ailments including preventing miscarriage and treating uterine hemorrhages after childbirth. Brazilian Indian women have for centuries valued its analgesic powers, and satchels of almost all midwives contain the root of this plant.

At the same time, it was traditionally included in the preparation of curares — the well-known South American arrow poison used in hunting to cause death by asphyxiation. This effect is due to its muscle-relaxant and neuromuscular blocking properties. The genus Abuta (in the broad popular sense) is native to tropical Central and South America, where it is represented by more than 30 species, some of which have been used by indigenous people to prepare curare, alkaloid-containing arrow and dart head poisons that paralyze prey.

2.2 Ayurvedic (Indian) Tradition

In Indian traditional medicine, Cissampelos pareira is a perennial climbing herb that is a member of the Menispermaceae family and is referred to as Ambastha or Laghu Patha. The Ayurvedic Pharmacopoeia of India attributes the herb's blood-purifying properties to the root and indicates its use in lactal disorders. The plant has been extensively used in the traditional medicinal system since ancient times for the treatment of numerous diseases such as ulcer, wound, rheumatism, fever, asthma, cholera, diarrhoea, inflammation, snakebite, malaria, rabies, and also recommended for blood purification.

2.3 Traditional Chinese Medicine

It is used in the treatment of a wide range of diseases in Traditional Chinese Medicine, Ayurveda, and western herbalism. In Chinese herbology, where it is called xí shēng téng (锡生藤) or yà hū nú (亞乎奴), it has been employed for its anti-inflammatory and analgesic properties.

2.4 African and Caribbean Traditions

Broader ethnobotanical surveys across Latin America and the Caribbean, as well as West and Central Africa, document allied uses for Cissampelos species in reproductive and urinary contexts, highlighting cross-cultural continuities in indications even as preparation methods and dosing vary. Contemporary accounts note applications for infections of the reproductive and urinary tracts and, in some traditions, for infertility, the facilitation of labor and delivery, and general pelvic health. In urban herbal markets, Abuta-derived powders, tinctures, and teas are incorporated into a wider pharmacopoeia of "woman's medicine," where they may be combined with other plants depending on regional practice and vendor knowledge.

2.5 Traditional Preparations

In South America, a standard decoction is generally prepared with the vine wood and taken two or three times daily in 1-cup doses. Documented traditional uses include preparation as an antispasmodic. Powdered abuta bark has also been used for menstrual complaints. The root, bark, and other above-ground parts are used as medicine.

3. Phytochemistry: Key Constituents and Active Compounds

3.1 Overview of Chemical Classes

The aerial parts contain a number of secondary plant metabolites like alkaloids, flavonoids, tannins, volatile oils, and glycosides. To date, approximately 54 phytomolecules have been isolated and characterized from C. pareira, including mainly isoquinoline alkaloids along with a few flavonoids, flavonoid glycosides, and fatty acids. Chemical fingerprinting of C. pareira carried out using HPTLC, HPLC, UPLC, LC-MS, and GC-MS revealed the presence of alkaloids (isoquinoline alkaloids), fatty acids, and flavonoid glycosides.

3.2 Alkaloid Profile

Cissampelos plants, including abuta, contain a group of plant chemicals called isoquinoline alkaloids. Since the late 1960s, these chemicals have received a great deal of attention and research. Out of thirty-eight alkaloids thus far discovered in abuta, one, called tetrandrine, is the most well documented.

The principal alkaloids identified include:

• Bisbenzylisoquinolines from the root: pelosine, hayatine (also known as l-curine or l-bebeerine), hayatinine (or (+)-4′′-O-methylcurine), hayatidine (also known as (−)-O-methylcurine), d-isochondrodendrine, cissampareine, tetrandrine, cycleanine, insularine, sepeerine, (+)-obaberine, (+)-obamegine, (+)-homoaromoline, and (−)-nor-N′-chondrocurine.
• Additional isoquinoline alkaloids: magnoflorine, magnocurarine, cissamine, curine, hayatinine, cycleanine; as well as cissampeline, (−)-cyclanoline, (−)-oblongine, trans-N-feruloyltyramine, and (+)-coclaurine, isolated through phytochemical analysis of the roots.
• Additional structural classes: benzylisoquinoline, benzyltetraisoquinoline, bisbenzyltetraisoquinoline, aporphine, proaporphine, tropolone-isoquinoline, azafluoranthene, and benzazepine alkaloids.

The broader reported chemical inventory of the plant also includes arachidic acid, bulbocapnine, corytuberine, 4-methylcurine, cyclanoline, dehydrodicentrine, dimethyltetrandrinium, grandirubrine, insularine, isomerubrine, laudanosine, linoleic acid, magnoflorine, menismine, norimeluteine, nor-ruffscine, nuciferine, pareirine, pareirubrine alkaloids, pareitropone, quercitol, stearic acid, and tetrandrine.

3.3 Part-Specific Alkaloid Distribution

The root contains deyamittin, cissamine, isochondrodendrine, l-curine, menismine, pareirine, hayatinine, berberines, essential oils, fixed oils, sterols, tetrandrine, cycleanine, dihydrodicentrine, insularine, bisbenzylisoquinoline, and dicentrine. The rhizomes contain hayatine, hayatidine, d-4″-O-methylberbeerine, L-berberines, isochondrodendrine, dicentrine, dehydrodicentrine, and insularine.

4. Mechanisms of Action

4.1 Tetrandrine

Clinical research over the years has found tetrandrine to have pain-relieving, anti-inflammatory, anticancerous, and fever-reducing properties. More than one hundred clinical studies also describe this chemical's promising actions against leukemia and cancer. This chemical has been synthesized, and several pharmaceutical companies are creating novel derivatives from it. The therapeutic dosages of tetrandrine used in these animal studies are much higher than one can reasonably obtain from natural abuta root or vine.

4.2 Hayatine and Neuromuscular Blocking

Hayatine (dl-berberine) is the principal alkaloid of the root. The derivatives of the alkaloid, methiodide and methochloride, are potent neuromuscular blocking agents and give the herb its antispasmodic property. Kupchan et al., in 1965, revealed that the methiodide of hayatine isolated from C. pareira showed powerful neuromuscular blocking activity when compared to that of d-tubocurarine chloride.

4.3 Anti-inflammatory Mechanisms

According to the arachidonic acid test, oral administration of an ethanolic extract of the aerial parts of Cissampelos pareira demonstrated considerable and dose-dependent anti-inflammatory action in the carrageenin test, based on interference with arachidonic acid pathways. Many alkaloids isolated from Cissampelos such as warifteine, methylwarifteine, berberine, hayatin, and hayatidin showed promising anti-allergic, immunosuppressive, antidepressant, anticancer, vasodilatory, and muscle-relaxant activities.

4.4 Antiviral Mechanisms

Alcoholic extract of Cissampelos pareira (designated "Cipa extract") was found to be a potent inhibitor of all four dengue virus serotypes (DENVs) in cell-based assays, assessed in terms of viral NS1 antigen secretion using ELISA, as well as viral replication based on plaque assays. Expression signatures revealed high positive scores with translation inhibitors such as emetine, and knockdown signatures of genes linked to the antiviral response. Further gene knockdown experiments revealed that Cipa exhibits antiviral activity in dengue-infected MCF7 cells potentially modulated through estrogen receptor pathways.

4.5 Anticancer Mechanisms

Compounds like cissampareine (also known as cissampeline) and pareirubrines A and B have been isolated from C. pareira and related species. Cissampareine, a bisbenzylisoquinoline alkaloid, has demonstrated significant cytotoxic activity against nasopharyngeal carcinoma cells. Alkaloids from the related species Abuta panurensis were effective against K562 and U937 tumor cells, showing practically no toxicity to normal cell lines Vero and human PBMC. These alkaloids also demonstrated immunomodulatory activity towards IL-6 and IL-8 interleukins.

4.6 Cholinesterase Inhibition

Alkaloids from Abuta reveal a wide range of pharmacological activities including muscle relaxant, antiplasmodial, inhibitory effects on acetylcholinesterase (AChE) and butyrylacetylcholinesterase enzymes, cytotoxic, and immunomodulatory activity. Stepharine is one of the most representative proaporphine alkaloids in the Menispermaceae family; proaporphine alkaloids are principally known for their potential to reversibly inhibit the acetylcholinesterase enzyme.

5. Scientific Evidence by Area of Use

5.1 Reproductive Health and Women's Conditions

Evidence level: Traditional/ethnopharmacological; limited preclinical; no robust human trials.

Abuta may function as an emmenagogue (menstrual flow stimulant). However, there are no human trials that have determined the safety and effectiveness of the abuta plant on the menstrual cycle. Future research is needed before a recommendation can be made. In the rainforests of South America, it has a rich history of use to treat all types of women's ailments including menstrual cramps, menorrhagia, and uterine haemorrhage, due to its profound relaxant effect on smooth muscle. Animal studies have confirmed antispasmodic and anti-inflammatory actions, but these have not been validated in controlled human trials.

5.2 Anti-inflammatory and Analgesic Activity

Evidence level: Preclinical (rodent models); no published human clinical trials.

The crude phytochemical extracts of different parts of C. pareira have been scientifically evaluated for anti-inflammatory (Amresh et al., 2007a), antiarthritic (Amresh et al., 2007b), antiulcer (Amresh et al., 2007c), immunomodulatory (Bafna and Mishra, 2010), and antipyretic (Singh et al., 2016b) activity. A 2007 study published in the Journal of Ethnopharmacology evaluated the anti-inflammatory activity of a 50% ethanolic root extract of C. pareira in rat models using acute, subacute, and chronic inflammation models, finding significant activity. These results, while promising, have not been translated into human studies.

5.3 Antimalarial Activity

Evidence level: In vitro and in silico; limited in vivo animal data; no human trials reported.

The application of C. pareira to treat malarial fever has been documented in some scientific literature. The hydromethanolic root extracts of C. pareira showed antiplasmodial efficacy against chloroquine-sensitive (NF54) and resistant (ENT30) strains of P. falciparum with an IC50 value of fewer than 10 μg/ml. The binding affinity of hayatinine and curine with identified antimalarial targets was further evaluated using MD-simulation analysis. All reported antimalarial findings remain at the preclinical or computational level.

5.4 Antiviral Activity (Dengue and SARS-CoV-2)

Evidence level: In vitro cell-based assays; animal model (dengue); no human clinical trials.

This is the first report of antiviral activity associated with Cissampelos pareira Linn. against dengue virus. Virus yield reduction assays showed that the Cipa extract could decrease viral titers by an order of magnitude. The extract conferred statistically significant protection against DENV infection using the AG129 mouse model. A preliminary evaluation showed that it had no adverse effects on platelet counts and RBC viability.

A subsequent study dissected the anti-coronavirus activity of the C. pareira extract (Cipa) using an integrative approach, analyzing signature similarities between predicted antiviral agents and Cipa using a connectivity map, followed by in vitro testing of anti-SARS-CoV-2 activity. Among the tested constituent compounds, pareiraine was reported for the first time from Cissampelos pareira in a study. Cissamine belongs to the protoberberine class of isoquinoline alkaloids and antiviral activity of cissamine was reported for the first time in this research. These findings are very preliminary and require validation in clinical settings.

5.5 Anticancer Activity

Evidence level: In vitro cell lines; one in vivo mouse model study; no human data.

A study evaluated Cissampelos pareira for in vitro cytotoxicity and in vivo antitumor activity against Dalton's Lymphoma Ascites (DLA) cells in Swiss mice. The plant was successively extracted using different solvents. In vitro cytotoxicity was assessed by the MTT assay. An in vivo study was carried out with methanol extract. Twenty-four hours after intraperitoneal inoculation of DLA cells in mice, the methanol extract was administered at 200 and 400 mg/kg body weight for 14 consecutive days. Ethanolic extracts of both stems and leaves showed notably high levels of total phenolic and flavonoid compounds. The total phenolic content was 58.26 ± 2.56 mg GAE/g dry weight in stem extract and 95.73 ± 1.76 mg GAE/g DW in leaf extract. The total flavonoid content was 27.23 ± 2.89 mg CE/g DW in stem extract and 82.68 ± 4.98 mg CE/g DW in leaf extract. The antileukemic tropoloisoquinoline alkaloids pareirubrine A and B have been specifically studied in vitro. No human oncology trials have been conducted.

5.6 Antifertility / Contraceptive Activity

Evidence level: Animal studies (rodents); traditional use; no human trials.

Cissampelos pareira Linn. is a perennial twining shrub that is used as an agent for birth control among rural people. Studies in female albino mice using methanolic leaf extract documented antifertility effects. These preclinical findings have not been translated to controlled human trials, and the traditional and scientific data on this use present apparent contradictions — the plant is also used traditionally to prevent miscarriage — illustrating that context, dose, and preparation may yield different biological outcomes.

5.7 Antimicrobial Activity

Evidence level: In vitro only.

An in vitro study to investigate the antibacterial activity of C. pareira showed that it had maximum activity against K. pneumoniae, P. aeruginosa, E. coli, and S. aureus. No clinical studies in humans have confirmed antimicrobial efficacy.

5.8 Cardiovascular and Other Activities

Pharmacological activity including analgesic and antipyretic, anti-inflammatory, anti-allergic, bronchodilator, immunomodulatory, memory-enhancing, antidepressant, neuroprotective, antimicrobial, antimalarial, antiparasitic, anti-ulcer, anticancer, anti-oxidant, cardiovascular, muscle-relaxant, hepatoprotective, antidiabetic, antidiarrhoeal, antifertility, and antivenom activity have been confirmed in vitro and/or in vivo for various Cissampelos species. The breadth of these preclinical findings reflects the chemical richness of the plant but should not be interpreted as evidence of clinical efficacy in any of these areas.

6. Dosage Forms and Preparations

The root, bark, and other above-ground plant parts are used as medicine. Abuta is available in the United States under several labels. Products include liquid extracts, tablets, capsules, and bulk ground herbal powders. In South America, a standard decoction is generally prepared with the vine wood and taken two or three times daily in 1-cup doses.

Regarding dosages used in laboratory research: one in vivo mouse study administered the methanol extract of C. pareira at 200 and 400 mg/kg body weight for 14 consecutive days. The alcoholic extract designated as the "Cipa extract" in dengue studies was assessed in cell-based assays, with virus yield reduction assays showing it could decrease viral titers by an order of magnitude. No human pharmacokinetic data or formally established human dosing regimens are documented in the peer-reviewed literature reviewed for this article.

7. Body Systems and Health Areas of Association

• Reproductive / Gynecological: Menstrual disorders (dysmenorrhea, menorrhagia), uterine hemorrhage, postpartum recovery, miscarriage prevention, labor facilitation, lactation support — primarily traditional, preclinical basis.
• Musculoskeletal / Neuromuscular: Antispasmodic and muscle-relaxant activity, antiarthritic effects — preclinical basis; historical connection to curare preparations.
• Immune / Inflammatory: Anti-inflammatory, antipyretic, immunomodulatory activity — preclinical basis.
• Infectious Disease: Antimalarial, antibacterial, antiviral (dengue, SARS-CoV-2) — primarily in vitro and animal data.
• Oncology: Cytotoxic activity against multiple cancer cell lines (leukemia, lymphoma, nasopharyngeal carcinoma) and mouse tumor models — entirely preclinical.
• Gastrointestinal: Antidiarrheal, antiulcer — preclinical.
• Urinary Tract: Diuretic, kidney and bladder infections — traditional use, limited preclinical data.
• Neurological: Acetylcholinesterase inhibition, memory-enhancing potential — in vitro and in silico only.

8. Safety Considerations and Known Interactions

8.1 General Safety Profile

When taken by mouth, there is not enough reliable information to know if abuta is safe or what the side effects might be. Despite the wide use of Cissampelos pareira in folk medicine, no study has been published in the scientific literature about its complete toxicological profile. There is partial data available on most of the pharmacological studies, along with incomplete toxicological screening. Future research needs to pay more attention to pharmacological studies of C. pareira via pre-clinical and clinical trials. Additionally, scientific validation of traditional knowledge of C. pareira is vital for ensuring safety, efficacy, and mechanism of action before clinical uses.

8.2 Neuromuscular Blocking Risk

The plant was traditionally included in the preparation of curares, the well-known South American arrow poison used to cause death by asphyxiation, due to its muscle-relaxant and neuromuscular blocking effect. Hayatine derivatives (methiodide and methochloride) are potent neuromuscular blocking agents. This pharmacological property — highly relevant at concentrated alkaloid doses — represents an important potential hazard when preparations are taken in large or unknown quantities.

8.3 Antifertility and Reproductive Risks

The plant has documented antifertility activity in rodent studies. It is used as an agent for birth control among rural people. This presents a direct safety concern in pregnancy, particularly because traditional use also claims the plant can prevent miscarriage — reflecting context- and dose-dependent effects that are not yet mechanistically resolved. There are no reliable safety data for pregnancy and lactation.

8.4 Toxicological Studies in Animals

A toxicological study by Amresh et al. (2008), published in the Journal of Ethnopharmacology, performed toxicological screening of traditional medicine Laghupatha (Cissampelos pareira) in experimental animals, as reported in J Ethnopharmacol 116: 454–460. This study examined the acute and subacute oral toxicity of a 50% aqueous ethanolic extract of the root in rodents and noted a moderate safety profile at tested doses; however, systemic toxicological data across the full range of human-relevant doses and long-term exposures remain incomplete.

8.5 Potential Drug Interactions

Based on the pharmacological properties of its known alkaloids, the following interaction categories are of mechanistic concern, though human clinical data on interactions are absent:

• Neuromuscular blocking agents and anesthetics: The alkaloid hayatine and its derivatives act comparably to d-tubocurarine; additive effects with neuromuscular blocking drugs used in surgery are plausible.
• Antidiabetic drugs: The berberine content of the plant has recognized hypoglycemic properties; pharmacodynamic potentiation with insulin or oral hypoglycemic agents is a theoretical concern.
• Antihypertensive drugs: The plant has been documented for antihypertensive activity, suggesting a theoretical additive interaction with antihypertensive medications.
• Uterotonic and tocolytic agents: Given the plant's dual traditional use in both stimulating and relaxing uterine tissue, interactions with oxytocic or tocolytic drugs would require careful monitoring.

8.6 Nomenclatural Safety Risk

References to abuta in herbal commerce today may apply to either Cissampelos pareira or to a completely different plant, Abuta grandiflora. This misidentification risk means consumers may inadvertently obtain a species with a different and insufficiently characterized chemical and toxicological profile. Verification via botanical Latin name is essential for any safety evaluation.

9. State of Evidence: Summary Assessment

Although some of the traditional uses have been well clarified and documented by modern pharmacological analysis, the correlation between pharmacological activities and particular phytoconstituents still needs to be validated. Furthermore, there is partial data available on most of the pharmacological studies, along with incomplete toxicological screening. Future research needs to pay more attention to pharmacological studies of C. pareira via pre-clinical and clinical trials. Additionally, scientific validation of traditional knowledge of C. pareira is vital for ensuring safety, efficacy, and mechanism of action before clinical uses.

As of the available literature, no published randomized controlled trials or systematic reviews in human subjects have established clinical efficacy for any specific therapeutic indication. The totality of the pharmacological evidence base consists of in vitro cell studies, computational (in silico) analyses, and animal models, supplemented by extensive traditional ethnobotanical documentation. The gap between preclinical promise — particularly in the areas of antimalarial, antiviral, anticancer, and anti-inflammatory activity — and validated human-use evidence remains large and represents the primary limitation for any evidence-based application.

References

• Kumari M, et al. (2021). Cissampelos pareira L.: A review of its traditional uses, phytochemistry, and pharmacology. Journal of Ethnopharmacology. ScienceDirect.
• PubMed abstract: Cissampelos pareira L.: A review of its traditional uses, phytochemistry, and pharmacology. PMID 33485976.
• Bezerra JL, et al. (2014). From arrow poison to herbal medicine — the ethnobotanical, phytochemical and pharmacological significance of Cissampelos (Menispermaceae). Journal of Ethnopharmacology. PubMed PMID 24997389.
• From arrow poison to herbal medicine – The ethnobotanical, phytochemical and pharmacological significance of Cissampelos (Menispermaceae). Journal of Ethnopharmacology. ScienceDirect.
• Nayak K, et al. (2015). Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes. PLOS Neglected Tropical Diseases. PMC4692392.
• Haider M, et al. (2021). Transcriptome analysis and connectivity mapping of Cissampelos pareira L. provides molecular links of ESR1 modulation to viral inhibition. Scientific Reports. PMC8505412.
• Anti-SARS-CoV-2 potential of Cissampelos pareira L. identified by connectivity map-based analysis and in vitro studies. PMC9028906.
• Anticancer activity of Cissampelos pareira against Dalton's Lymphoma Ascites bearing mice. PMC4159910.
• Alkaloids of Abuta panurensis Eichler: In silico and in vitro study of acetylcholinesterase inhibition, cytotoxic and immunomodulatory activities. PLOS ONE. PMC7523975.
• In Vitro and In Silico Evaluation of Cholinesterase Inhibition by Alkaloids from Branches of Abuta panurensis Eichler. PMC9144276.
• Phytochemical Screening and In Vitro Antioxidant and Anticancer Evaluation of Stem and Leaf Extracts of Cissampelos pareira L. PMC12274098.
• Bisbenzylisoquinolines from Cissampelos pareira L. as antimalarial agents: Molecular docking, pharmacokinetics analysis, and molecular dynamic simulation studies. Computational Biology and Chemistry. ScienceDirect.
• Amresh G, et al. (2008). Toxicological screening of traditional medicine Laghupatha (Cissampelos pareira) in experimental animals. Journal of Ethnopharmacology. ScienceDirect.
• Ethnomedicinal Uses, Phytochemistry and Pharmacology of Cissampelos pareira: A Review. ResearchGate.
• Tropical Plant Database: Abuta (Cissampelos pareira). Rain-Tree Nutrition.
• Wikipedia: Cissampelos pareira.
• Phytochemical investigation and pharmacognostic standardization of Cissampelos pareira root. PubMed PMID 23661865.
• A Review of the Phytochemistry, Pharmacology, and Traditional Applications of Cissampelos pareira. IJRASET.
• Plants of the World Online: Abuta grandifolia. Kew Science.